Brenipatide for alcoholism

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 15 Oct 2025: Trial started, NCT07219966
  2. 16 Oct 2025: Trial started, NCT07219953
  3. 22 Oct 2025: Trial registered, NCT07219953
  4. 22 Oct 2025: Trial registered, NCT07219966

The trials

NCT07219953: A Study of Brenipatide in Participants With Alcohol Use Disorder

State
Under way
Phase
Phase 3
People
1,100 planned
Started
16 Oct 2025
Primary completion
Apr 2028
Arms
LY3537031 Period 1, LY3537031 Period 2
Results
None posted
  1. 16 Oct 2025: Trial started
  2. 22 Oct 2025: Trial registered

NCT07219966: A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

State
Under way
Phase
Phase 3
People
1,100 planned
Started
15 Oct 2025
Primary completion
Apr 2028
Arms
LY3537031 Period 1, LY3537031 Period 2
Results
None posted
  1. 15 Oct 2025: Trial started
  2. 22 Oct 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.